KKR invests $200m in India's Gland
This article was originally published in Scrip
Executive Summary
Niche verticals such as injectables continue to attract private equity (PE) interest in India, with the global investment firm, KKR, acquiring a minority stake in Gland Pharma for about $200m – the largest PE investment in a local pharmaceutical firm in recent times.